 Anhui Sun Angel pharmaceutical Co.,Ltd, a fully owned subsidiary of Anhui Lianchuang Biological Medicine Co.,Ltd. , is dedicated to the production of pharmaceutical APIs.
Anhui Sun Angel Pharmaceutical is located in the Biomedical Industrial Park of Huainan National Economic and Technical Development Zone. It occupies an area of 60,000㎡ with total investment RMB200 million. Now it has established two workshops that meets GMP requirements. A workshop for the production of inhibitor SGLT-2 is under construction. In addition, the construction for GLP-1 receptor stimulant workshop is under planning as well. Auxiliary facilities include warehouses, fire equipments, environment-protection pool, R&D office building, etc.
Main products including:
Diabetes APIs: Sglt-2 inhibitors such as Dapagliflozin, Canagliflozin, Empagliflozin, etc; DPP4-1 inhibitors such as Alogliptin benzoate, etc; GLP-1 inhibitors such as Liraglutide, etc; insulin secretagogues such as Repaglinide, etc.
.....
|
中文 
ENGLISH
Link: 
